These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Validation and development of a predictive paradigm for hemotoxicology using a multifunctional bioluminescence colony-forming proliferation assay. Rich IN; Hall KM Toxicol Sci; 2005 Oct; 87(2):427-41. PubMed ID: 16002476 [TBL] [Abstract][Full Text] [Related]
4. Introduction: drug induced diseases I. Saltiel M J Pharm Pract; 2014 Oct; 27(5):429. PubMed ID: 25249587 [No Abstract] [Full Text] [Related]
5. The Jewish Hospital of St. Louis therapeutic grand rounds number 3. Drug-induced blood dyscrasias. Rosenblum D; Wessler S; Avioli LA Arch Intern Med; 1973 May; 131(5):750-2. PubMed ID: 4512788 [No Abstract] [Full Text] [Related]
6. Metabolic activation in drug allergies. Park BK; Naisbitt DJ; Gordon SF; Kitteringham NR; Pirmohamed M Toxicology; 2001 Feb; 158(1-2):11-23. PubMed ID: 11164988 [TBL] [Abstract][Full Text] [Related]
9. Adverse hematologic effects of drugs. Pochedly C; Ente G Pediatr Clin North Am; 1972 Nov; 19(4):1095-111. PubMed ID: 4404210 [No Abstract] [Full Text] [Related]
10. Allergy and adverse drug reactions. VanArsdel PP J Am Acad Dermatol; 1982 May; 6(5):833-45. PubMed ID: 6212600 [TBL] [Abstract][Full Text] [Related]
11. [[The applications of in vitro culture [corrected] technics to hematological diagnosis]. Florensa L Med Clin (Barc); 1990 Oct; 95(14):548-55. PubMed ID: 2084437 [No Abstract] [Full Text] [Related]
12. The use of a three compartment in vitro model to investigate the role of hepatic drug metabolism in drug-induced blood dyscrasias. Tingle MD; Park BK Br J Clin Pharmacol; 1993 Jul; 36(1):31-8. PubMed ID: 8373710 [TBL] [Abstract][Full Text] [Related]
13. Commentary: The French Revolution, Toxicity Biomarkers and Digging Holes. Budny JA Int J Toxicol; 2014 Jul; 33(4):268-270. PubMed ID: 25097226 [No Abstract] [Full Text] [Related]
14. [Side effects of drugs]. von Kress HF Munch Med Wochenschr; 1968 Aug; 110(35):1905-12. PubMed ID: 5695701 [No Abstract] [Full Text] [Related]
15. Introduction to the proceedings of the Speed and Safety in Drug Discovery Symposium hosted by the Safer Medicines Trust. Preface. Clotworthy M; Archibald K Altern Lab Anim; 2009 Sep; 37 Suppl 1():i-iii. PubMed ID: 19953739 [No Abstract] [Full Text] [Related]
16. The detection of in vivo hematotoxicity of benzene by in vitro liquid bone marrow cultures. Harigaya K; Miller ME; Cronkite EP; Drew RT Toxicol Appl Pharmacol; 1981 Sep; 60(2):346-53. PubMed ID: 7281193 [No Abstract] [Full Text] [Related]
17. Toxicology Strategies for Drug Discovery - Present and Future: Introduction. Humphreys WG; Will Y; Guengerich FP Chem Res Toxicol; 2016 Apr; 29(4):437. PubMed ID: 27087588 [No Abstract] [Full Text] [Related]
18. Nonhuman primates in evaluation of hematotoxicity. Saslaw S; Carlisle HN Ann N Y Acad Sci; 1969 Jul; 162(1):646-58. PubMed ID: 4979575 [No Abstract] [Full Text] [Related]
19. BLOOD dyscrasia following the use of chloramphenicol. J Am Med Assoc; 1952 Jun; 149(9):840. PubMed ID: 14927468 [No Abstract] [Full Text] [Related]
20. Deaths from drugs. An analysis of drug-induced deaths reported to the Swedish Adverse Drug Reaction Committee during a five-year period (1966-1970). Böttiger LE; Norlander M; Strandberg I; Westerholm B J Clin Pharmacol; 1974; 14(8):401-7. PubMed ID: 4851273 [No Abstract] [Full Text] [Related] [Next] [New Search]